4D Molecular Therapeutics, Inc. (FDMT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 434.48M |
| Enterprise Value | 395.65M |
| P/E Ratio | -4.36 |
| PEG Ratio | -0.99 |
| Price/Sales Ratio | 6.87 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 6.28 |
| Enterprise/EBITDA | -3.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.82 |
| Operating Margin | -2.03 |
| Return On Assets | -0.31 |
| Return On Equity | -0.37 |
| Revenue | 85.21M |
| Revenue/Share | 1.3 |
| Gross Profit | 77.58M |
| EBITDA | -132.48M |
| Net Income | -140.11M |
| Diluted EPS | -2.42 |
| Total Cash | 390.89M |
| Total Cash/Share | 5.74 |
| Total Debt | 20.54M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 9.34 |
| Book Value Per Share | 6.64 |
| 52-Week Change | 207.69 |
| 52-Week High | 12.34 |
| 52-Week Low | 3.68 |
| Moving Average 50 Days | 9.44 |
| Moving Average 200 Days | 9.26 |
| Average Volume | 795,720 |
| Shares Outstanding | 52.28M |
| % Held by Institutions | 87.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |